Metabolite sample testing in CKD patients post-kidney transplantation revealed a significant decrease in concentrations of key renal function indicators (creatinine, eGFR, cystatin C) with elevated N-acetylornithine levels (57). The gene discussed is CST3; the disease is chronic kidney disease.